![Pharming Group NV](/common/images/company/EU_PHARM.png)
Pharming Group NV (PHARM)
EU
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 126.78M | 166.19M | 214.48M | 228.21M | 418.45M | 397.32M | 425.8M | 462.85M |
Total Current Assets | 62.19M | 88.25M | 115.44M | 106.5M | 263.21M | 249.44M | 277.5M | 316.34M |
Cash and Equivalents | 31.89M | 58.66M | 80.31M | 66.3M | 205.16M | 191.92M | 207.34M | 61.74M |
Total Non-Current Assets | 27.47M | 16.11M | 61.75M | 104.68M | 183.44M | 192.92M | 204.64M | 218.78M |
Total Liabilities | 99.32M | 150.08M | 152.73M | 123.53M | 235.02M | 204.4M | 221.16M | 244.07M |
Total Current Liabilities | 51.38M | 60.74M | 82.6M | 101.89M | 76.85M | 46.77M | 59.7M | 77.97M |
Total Non-Current Liabilities | 88.93M | 148.89M | 107.56M | 26.01M | 316.13M | 315.09M | 322.92M | 302.7M |
Total Equity | 27.47M | 16.11M | 61.75M | 104.68M | 183.44M | 192.92M | 204.64M | 218.78M |
Common Equity | 4.56M | 5.79M | 6.22M | 6.31M | 7.31M | 7.43M | 7.51M | 7.67M |
Retained Earnings | -279.03M | -352.56M | -333.64M | -297.62M | -295.62M | -273.17M | -256.43M | -265.26M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.